american diabetes association pancreatitis history glp-1 receptor agonist Clinical Focus on Agonists in Type 2 Mellitus GLP-1 Receptor Agonists for the

Med Arch

In another case report by Fujino et al., a 31-year-old female patient on semaglutide for T2DM underwent EGD in preparation for bariatric surgery

A series of 10 phase 3 multicenter, randomized clinical studies as part of the Peptide InnOvatioN for Early diabetes tReatment (PIONEER) program were conducted to compare the efficacy and safety of oral semaglutide with either placebo or active comparators [2131]

Prior efforts to treat obesity demonstrate that sustained weight reduction is a Herculean task--thus it may be the case that GLP-1 agents will need to be administered chronically to sustain anti-obesity benefits

doi: 10.1111/dom.12257

This makes them highly effective for individuals with type 2 diabetes, especially those who struggle to control their blood sugar with other medications